Blog

MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
January 22, 2026 by Susan Mohr Allocation Strategy: Bard (MDL 2846) vs. Covidien (MDL 3029) EXECUTIVE SUMMARY The “Hernia Mesh” bucket is no longer a single asset class. As we enter Q1 2026, the litigation has bifurcated into two distinct phases. Bard has transitioned into a mature “Administration & Cleanup” phase, where value is found only in specific, high-damage claims. Covidien,… Continue reading MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
Bard Hernia Mesh Litigation Covidien Litigation
Solving the “Fake Lead” Crisis in Mass Torts with AI
January 22, 2026 by Susan Mohr The end of the “Lead Broker” model in MDLs With MDL judges increasingly scrutinizing plaintiff inventories and defense counsel flagging “bot” submissions in high-profile torts, the integrity of legal lead generation is facing a crisis. I am writing to share how Mohr Marketing is addressing this head-on. We have moved away from the traditional “Lead… Continue reading Solving the “Fake Lead” Crisis in Mass Torts with AI
Leads for Attorneys legal marketing
The Bard Hernia Mesh Landscape in 2026
January 21, 2026 by Susan Mohr Bard Settlement vs. Covidien Growth: Where to Put Your Budget in 2026 For the last five years, MDL 2846 (In re: Davol, Inc./C.R. Bard, Inc.) has been a cornerstone of many mass tort inventories. However, following Becton Dickinson’s October 2024 announcement of a global settlement framework (approx. $1.9 billion reserved for ~38,000 claims), the strategy… Continue reading The Bard Hernia Mesh Landscape in 2026
Bard Hernia Mesh Litigation Covidien Litigation Hernia Mesh Update
The “Hernia Mesh” bucket is no longer a single asset class
January 21, 2026 by Susan Mohr Mohr Marketing Launches “Post-Settlement” Protocol for Bard Mesh; Opens New Acquisition Channels for Emerging Covidien Litigation Dual-strategy for 2026: Strict “Tier 1” filtration for mature Bard dockets and aggressive growth focus for Covidien (MDL 3029). Mohr Marketing, a specialized digital agency for the legal sector, today announced a strategic overhaul of its hernia mesh acquisition… Continue reading The “Hernia Mesh” bucket is no longer a single asset class
Bard Hernia Mesh Litigation Covidien Litigation Hernia Mesh Update
Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket
January 21, 2026 by Susan Mohr Mohr Marketing Launches “Post-Settlement” Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket Control Mohr Marketing, a specialized digital agency for the legal sector, today announced the launch of its “Tier 1” Bard Intake Protocol, a proprietary acquisition program designed specifically for the post-settlement administration phase of the C.R. Bard Hernia Mesh litigation (MDL… Continue reading Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket
Bard Hernia Mesh Litigation Covidien Litigation Hernia Mesh Update
The 2026 MVA Lead Generation Compliance Checklist
January 20, 2026 by Susan Mohr Protecting Your Firm from Barratry, Capping, and Ethical Violations in the AI Era Disclaimer: This checklist is for informational purposes only and does not constitute legal advice. Attorneys should always consult their specific State Bar rules regarding advertising and solicitation. Part 1: The “Source & Origin” Test How is the lead generated? This is the… Continue reading The 2026 MVA Lead Generation Compliance Checklist
Compliance Shield
⚠️ Your “Inventory” might be at risk (Read this)
January 19, 2026 by Susan Mohr Why “Brokered” Mass Tort cases are becoming a liability. Switch to Direct AI Acquisition. In the high-stakes world of Mass Torts, “Data Integrity” is the new gold. If you are building your docket by purchasing “signed cases” from third-party aggregators, you are facing three major risks: Dual Representation: The claimant has already been sold to… Continue reading ⚠️ Your “Inventory” might be at risk (Read this)
Mass Tort Lead Generation
Why Mass Tort Firms Must Own Their Lead Generation
January 17, 2026 by Susan Mohr The “Broker Chain” Apocalypse: Why Mass Tort Firms Must Own Their Lead Generation in 2026 Category: Mass Tort Marketing / Legal Ethics If you are a Mass Tort attorney, you know the nightmare: You buy a docket of 500 cases from a vendor, only to find that 30% are “dual rep” (already signed by another… Continue reading Why Mass Tort Firms Must Own Their Lead Generation
Compliance Program Mass Tort Lead Generation
Stop Buying “Black Box” Leads. It’s Time for a Glass Pipeline.
January 16, 2026 by Susan Mohr Are you tired of handing your law firm’s marketing budget over to a “Black Box”? For too long, attorneys have been trapped in a cycle of uncertainty, buying leads from vendors without knowing where they originated, what the ads looked like, or who else purchased the same data. At Mohr Marketing, we are shattering that… Continue reading Stop Buying “Black Box” Leads. It’s Time for a Glass Pipeline.
New “Joint Advertising & Compliance Program”
January 16, 2026 by Susan Mohr Mohr Marketing Disrupts Legal Lead Generation with New “Joint Advertising & Compliance Program,” Eliminating TCPA Risks for Law Firms [Allentown, PA] – [Friday 16, 2026] – As law firms across the country face increasing scrutiny from State Bar Associations and a rise in TCPA litigation regarding client acquisition, Mohr Marketing announces the launch of its… Continue reading New “Joint Advertising & Compliance Program”
Compliance Shield Joint Advertising
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
Recent Posts
Categories
Archives

Copyright © 1994-2025 Mohr Marketing, LLC. All Rights Reserved.

Secret Link